Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remazolam vs propofol vs sevoflurane on intracranial pressure in Trendelenburg colorectal cancer surgery
ChiCTR2500107926Phase 4Not yet recruiting
- Sponsor
- The First People's Hospital of Neijiang City
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) comparing Remimazolam group, Propofol group and Sevoflurane group (3 arms). Primary endpoint: Optic Nerve Sheath Diameter/Eyeball Transverse Diameter (ONSD/ETD). Planned start Aug 2025; status: not yet recruiting.
02
Drugs
remimazolampropofolsevoflurane
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2500107926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107926.